Item 16. Form 10-K Summary
7K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| JABIL INC. Registrant | ||||||||
| Date: October 25, 2022 | By: | /s/ MARK T. MONDELLO | ||||||
| Mark T. Mondello Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL THESE PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mark T. Mondello and Michael Dastoor and each of them, jointly and severally, his or her attorneys-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each said attorneys-in-fact or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date | ||||||||||||
| By: | /s/ MARK T. MONDELLO | Chairman of the Board of Directors and Chief Executive Officer (Principal Executive Officer) | October 25, 2022 | |||||||||||
| Mark T. Mondello | ||||||||||||||
| By: | /s/ STEVEN A. RAYMUND | Lead Independent Director | October 25, 2022 | |||||||||||
| Steven A. Raymund | ||||||||||||||
| By: | /s/ THOMAS A. SANSONE | Vice Chairman of the Board of Directors | October 25, 2022 | |||||||||||
| Thomas A. Sansone | ||||||||||||||
| By: | /s/ MICHAEL DASTOOR | Chief Financial Officer (Principal Financial and Accounting Officer) | October 25, 2022 | |||||||||||
| Michael Dastoor | ||||||||||||||
| By: | /s/ ANOUSHEH ANSARI | Director | October 25, 2022 | |||||||||||
| Anousheh Ansari | ||||||||||||||
| By: | /s/ MARTHA F. BROOKS | Director | October 25, 2022 | |||||||||||
| Martha F. Brooks | ||||||||||||||
| By: | /s/ CHRISTOPHER S. HOLLAND | Director | October 25, 2022 | |||||||||||
| Christopher S. Holland | ||||||||||||||
| By: | /s/ JOHN C. PLANT | Director | October 25, 2022 | |||||||||||
| John C. Plant | ||||||||||||||
| By: | /s/ DAVID M. STOUT | Director | October 25, 2022 | |||||||||||
| David M. Stout | ||||||||||||||
| By: | /s/ KATHLEEN A. WALTERS | Director | October 25, 2022 | |||||||||||
| Kathleen A. Walters |
SCHEDULE II
JABIL INC. AND SUBSIDIARIES
SCHEDULE OF VALUATION AND QUALIFYING ACCOUNTS
(in millions)
| Balance at Beginning of Period | Additions and Adjustments Charged to Costs and Expenses | Additions/ (Reductions) Charged to Other Accounts | Write-offs | Balance at End of Period | ||||||||||||||||||||||||||||
| Reserve for excess and obsolete inventory: | ||||||||||||||||||||||||||||||||
| Fiscal year ended August 31, 2022 | $ | 85 | $ | 23 | $ | — | $ | (26) | $ | 82 | ||||||||||||||||||||||
| Fiscal year ended August 31, 2021 | $ | 85 | $ | 33 | $ | — | $ | (33) | $ | 85 | ||||||||||||||||||||||
| Fiscal year ended August 31, 2020 | $ | 70 | $ | 60 | $ | — | $ | (45) | $ | 85 | ||||||||||||||||||||||
| Balance at Beginning of Period | Additions Charged to Costs and Expenses | Additions/ (Reductions) Charged to Other Accounts | Reductions Charged to Costs and Expenses | Balance at End of Period | ||||||||||||||||||||||||||||
| Valuation allowance for deferred taxes: | ||||||||||||||||||||||||||||||||
| Fiscal year ended August 31, 2022 | $ | 353 | $ | 19 | $ | (31) | $ | (60) | $ | 281 | ||||||||||||||||||||||
| Fiscal year ended August 31, 2021 | $ | 341 | $ | 18 | $ | — | $ | (6) | $ | 353 | ||||||||||||||||||||||
| Fiscal year ended August 31, 2020 | $ | 288 | $ | 54 | $ | 9 | $ | (10) | $ | 341 |
See accompanying report of independent registered public accounting firm.
Previous: Item 15. Exhibits and Financial Statement Schedules